← Back to catalogue

Lacriflow

FDA UDI

Class U (US FDA UDI)

by Kaneka Corp.

Identity

Trade Name
LACRIFLOW FDA UDI
Generic Name
Lacrimal tube FDA UDI
Device Name
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction. FDA UDI
Model / Reference
LF-R105A FDA UDI
Description
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction. FDA UDI

Identifiers

Primary DI / UDI-DI
04540778140868 FDA UDI
FDA Product Code
OKS FDA UDI
GMDN Term
Lacrimal tube FDA UDI

Classification

Device Class
U FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI
MRI Safety
MR Unsafe FDA UDI

Dimensions & Sizes

Size
Length — 105 Millimeter FDA UDI

Category: Lacrimal tube

Lacriflow by Kaneka Corp. — Class U — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Lacrimal tube.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Kaneka Corp.

Sources (1)

  • FDA UDI 257d65a8-23e2-4ce0-a283-b69482c24ba8 36 fields · synced Jun 8, 2026